Clinical Trial Update: Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ceftazidime-avibactam to doripenem followed by oral therapy for adults with complicated urinary tract infections, including acute pyelon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• Doripenem (Doripenem)
• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: Pfizer | Conditions: Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis | Phase 3 | Status: COMPLETED | Results posted: 2016-03-09